• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial.

作者信息

Yao Yin, Huang Ao, Deng Yi-Ke, Liu Yan, Zhu Hong-Yu, Wang Nan, Wang Zhe-Zheng, Zhu Rong-Fei, Yu Di, Liu Zheng

机构信息

Tongji Hospital affiliated to Huazhong University of Science and Technology Wuhan, China.

The University of Queensland Brisbane, Australia.

出版信息

Am J Respir Crit Care Med. 2022 Sep 15;206(6):780-783. doi: 10.1164/rccm.202203-0608LE.

DOI:10.1164/rccm.202203-0608LE
PMID:35649178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9799121/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9155/9799121/13b42588d7db/rccm.202203-0608LEf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9155/9799121/b5728193dad1/rccm.202203-0608LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9155/9799121/13b42588d7db/rccm.202203-0608LEf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9155/9799121/b5728193dad1/rccm.202203-0608LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9155/9799121/13b42588d7db/rccm.202203-0608LEf2.jpg

相似文献

1
Allergen Immunotherapy Reverses Immune Response to SARS-CoV-2 Vaccine in Patients with Allergic Rhinitis: A Prospective Observational Trial.变应原免疫疗法逆转过敏性鼻炎患者对SARS-CoV-2疫苗的免疫反应：一项前瞻性观察性试验。
Am J Respir Crit Care Med. 2022 Sep 15;206(6):780-783. doi: 10.1164/rccm.202203-0608LE.
2
[The research progress of mechanism of allergen immunotherapy in allergic rhinitis].[变应性鼻炎变应原免疫治疗机制的研究进展]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Dec;35(12):1149-1152. doi: 10.13201/j.issn.2096-7993.2021.12.021.
3
[ALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINITIS: TO INTRODUCE SUBCUTANEOUS IMMUNOTHERAPY].[变应性鼻炎的变应原免疫疗法：介绍皮下免疫疗法]
Arerugi. 2022;71(2):85-91. doi: 10.15036/arerugi.71.85.
4
[CLASSIFICATION OF RHINITIS AND TREATMENT FOR SEVERE ALLERGIC RHINITIS].[鼻炎的分类及重度过敏性鼻炎的治疗]
Arerugi. 2024;73(2):155-159. doi: 10.15036/arerugi.73.155.
5
[ALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINITIS].[变应性鼻炎的变应原免疫治疗]
Arerugi. 2015 May;64(5):693-8; quiz 698-9.
6
[The allergen-specific immunotherapy for allergic rhinitis].[变应性鼻炎的变应原特异性免疫疗法]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 May 7;55(5):562-568. doi: 10.3760/cma.j.cn115330-20200108-00014.
7
Immunotherapy: Treating with Fewer Allergens?免疫疗法：用更少的变应原进行治疗？
Otolaryngol Clin North Am. 2017 Dec;50(6):1153-1165. doi: 10.1016/j.otc.2017.08.012. Epub 2017 Sep 28.
8
Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.皮下和舌下免疫疗法治疗变应性鼻结膜炎和哮喘的疗效与安全性
Otolaryngol Clin North Am. 2017 Dec;50(6):1111-1119. doi: 10.1016/j.otc.2017.08.011. Epub 2017 Sep 28.
9
Algorithms in allergen immunotherapy in allergic rhinoconjunctivitis.变应性鼻结膜炎的变应原免疫疗法中的算法
Allergy. 2020 Sep;75(9):2411-2414. doi: 10.1111/all.14270. Epub 2020 Apr 19.
10
Advances and highlights in allergic rhinitis.变应性鼻炎的研究进展和热点。
Allergy. 2021 Nov;76(11):3383-3389. doi: 10.1111/all.15044. Epub 2021 Aug 17.

引用本文的文献

1
Impact of COVID-19 on adverse reactions to subcutaneous specific immunotherapy in children:a retrospective cohort study.新型冠状病毒肺炎对儿童皮下特异性免疫治疗不良反应的影响：一项回顾性队列研究
BMC Infect Dis. 2024 Aug 7;24(1):794. doi: 10.1186/s12879-024-09702-5.
2
SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series.SARS-CoV-2 加强疫苗接种剂量可显著延长体液免疫应答半衰期，超过初级系列。
Sci Rep. 2024 Apr 18;14(1):8426. doi: 10.1038/s41598-024-58811-3.
3
Does allergen immunotherapy impact the susceptibility and severity of COVID-19?

本文引用的文献

1
Selected Bibliography of Recent Research in COVID-19.新型冠状病毒肺炎近期研究精选参考文献
Am J Respir Crit Care Med. 2022 Dec 15;206(12):1548-1562. doi: 10.1164/rccm.202202-0277UP.
2
The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis.度普利尤单抗治疗对特应性皮炎患者严重急性呼吸综合征冠状病毒2-冠状病毒病2019抗体反应的影响。
Ann Allergy Asthma Immunol. 2022 Jun;128(6):734-736. doi: 10.1016/j.anai.2022.03.019. Epub 2022 Mar 26.
3
Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma.
变应原免疫疗法会影响新型冠状病毒肺炎的易感性和严重程度吗？
Clin Transl Allergy. 2023 Apr;13(4):e12247. doi: 10.1002/clt2.12247.
4
Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis.针对感染性因子的疫苗接种与变应原特异性免疫疗法：批判性分析。
Allergol Select. 2023 Mar 31;7:84-89. doi: 10.5414/ALX02390E. eCollection 2023.
接受生物疗法治疗哮喘的患者中COVID-19疫苗反应降低。
Am J Respir Crit Care Med. 2022 May 15;205(10):1243-1245. doi: 10.1164/rccm.202111-2496LE.
4
Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma.变应原免疫疗法对伴有和不伴有哮喘的变应性鼻炎的多种免疫机制
J Allergy Clin Immunol. 2022 Mar;149(3):791-801. doi: 10.1016/j.jaci.2022.01.016. Epub 2022 Jan 29.
5
T 2 cells associate with enhanced humoral immunity to SARS-CoV-2 inactivated vaccine in patients with allergic rhinitis.在过敏性鼻炎患者中，T2细胞与针对新冠病毒灭活疫苗的体液免疫增强相关。
Clin Transl Med. 2022 Jan;12(1):e717. doi: 10.1002/ctm2.717.
6
Selenium-GPX4 axis protects follicular helper T cells from ferroptosis.硒-谷胱甘肽过氧化物酶 4 轴保护滤泡辅助性 T 细胞免于铁死亡。
Nat Immunol. 2021 Sep;22(9):1127-1139. doi: 10.1038/s41590-021-00996-0. Epub 2021 Aug 19.
7
Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy.变的染色质景观在循环 T 滤泡辅助和调节细胞在草花粉皮下和舌下免疫治疗。
J Allergy Clin Immunol. 2021 Feb;147(2):663-676. doi: 10.1016/j.jaci.2020.10.035. Epub 2020 Nov 6.
8
Roles of follicular helper and regulatory T cells in allergic diseases and allergen immunotherapy.滤泡辅助性T细胞和调节性T细胞在过敏性疾病及变应原免疫治疗中的作用。
Allergy. 2021 Feb;76(2):456-470. doi: 10.1111/all.14639. Epub 2020 Nov 4.
9
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology.度普利尤单抗、重度哮喘气道反应与严重急性呼吸综合征冠状病毒2血清学
Allergy. 2021 Mar;76(3):957-958. doi: 10.1111/all.14534. Epub 2020 Aug 24.
10
Allergen immunotherapy improves defective follicular regulatory T cells in patients with allergic rhinitis.变应原免疫疗法改善变应性鼻炎患者缺陷性滤泡调节性 T 细胞。
J Allergy Clin Immunol. 2019 Jul;144(1):118-128. doi: 10.1016/j.jaci.2019.02.008. Epub 2019 Feb 21.